Artículos por temáticas

Pathophysiologic Basis of Movement Disorders.

Wichmann T.

Prog Neurol Surg. 2018;33:13-24. doi: 10.1159/000480718. Epub 2018 Jan 12.

Movement Disorders and Deep Brain Stimulation in the Middle East.

Siddiqui JH, Bhatti D, Alsubaie F, Bajwa JA.

World Neurosurg. 2018 Feb 13. pii: S1878-8750(18)30293-6. doi: 10.1016/j.wneu.2018.02.023. [Epub ahead of print] No abstract available.

Detecting anxiety in individuals with Parkinson disease: A systematic review.

Mele B, Holroyd-Leduc J, Smith EE, Pringsheim T, Ismail Z, Goodarzi Z.

Neurology. 2018 Jan 2;90(1):e39-e47. doi: 10.1212/WNL.0000000000004771. Epub 2017 Dec 6.

Movement Disorders in Treatable Inborn Errors of Metabolism.

Ebrahimi-Fakhari D, Van Karnebeek C, Münchau A.

Mov Disord. 2018 Dec 17. doi: 10.1002/mds.27568. [Epub ahead of print] Review.

Abstracts of the 2018 International Congress of Parkinson's Disease and Movement Disorders(®).

[No authors listed]

Mov Disord. 2018 Oct;33 Suppl 2:S1-S929. doi: 10.1002/mds.116. No abstract available.

A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress.

Trist BG, Hare DJ, Double KL.

Cell Chem Biol. 2018 Jul 19;25(7):807-816. doi: 10.1016/j.chembiol.2018.05.004. Epub 2018 May 31. Review.

Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Quik M, Boyd JT, Bordia T, Perez X.

Nicotine Tob Res. 2018 Aug 17. doi: 10.1093/ntr/nty063. [Epub ahead of print]

The expanding spectrum of paroxysmal movement disorders: update from clinical features to therapeutics.

McGovern EM, Roze E, Counihan TJ.

Curr Opin Neurol. 2018 May 15. doi: 10.1097/WCO.0000000000000576. [Epub ahead of print]

New Imaging Markers for Movement Disorders.

Ghadery C, Strafella AP.

Curr Neurol Neurosci Rep. 2018 Apr 3;18(5):22. doi: 10.1007/s11910-018-0830-x. Review.

[Glucose transporter 1 deficiency syndrome: features of movement disorders, diagnosis and treatment].

Ji XN, Xu CJ, Gao ZJ, Chen SH, Xu KM, Chen Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2018 Mar;20(3):209-213. Chinese.

[Movement disorders emergencies].

Burkhard PR, Horvath J, Fleury V, Zacharia A, Bally JF, Bereau M, Bouthour W, Lüscher C, Krack P.

Rev Med Suisse. 2018 Apr 25;14(604):888-891. French.

Telemedicine Use for Movement Disorders: A Global Survey.

Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E.

Telemed J E Health. 2018 Mar 22. doi: 10.1089/tmj.2017.0295. [Epub ahead of print]

Current and Expected Advances in Deep Brain Stimulation for Movement Disorders.

Bari AA, Thum J, Babayan D, Lozano AM.

Prog Neurol Surg. 2018;33:222-229. doi: 10.1159/000481106. Epub 2018 Jan 12.

The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.

Nelson MP, Boutin M, Tse TE, Lu H, Haley ED, Ouyang X, Zhang J, Auray-Blais C, Shacka JJ.

Neurobiol Dis. 2018 Feb;110:68-81. doi: 10.1016/j.nbd.2017.11.006. Epub 2017 Dec 2.

Single-Event Multilevel Surgery to Correct Movement Disorders in Children with Cerebral Palsy.

Wick JM, Feng J, Raney E, Aiona M.

AORN J. 2018 Nov;108(5):516-531. doi: 10.1002/aorn.12402.